Sputnik V study: More people died after taking Pfizer jab than AstraZeneca

<p>
<strong>Russian Covid vaccine Sputnik V, which is now the third Covid-19 vaccine in India, has claimed that the available public data suggests more people died after taking the Pfizer jab than AstraZeneca.</strong></p>
<p>
"Sputnik V study shows that there are significantly more deaths following vaccination with Pfizer than with AstraZeneca vaccine per 1 million administered doses, based on official publicly available data by 13 international health regulators," Sputnik V said in a tweet late on Friday.<br />
<br />
The causes of such major discrepancies in the number of death "cases among different vaccines should be the focus of honest scientific and public discussion," it added.<br />
<br />
Both Pfizer and AstraZeneca were yet to react to the Sputnik V study.<br />
<br />
In January, 23 elderly patients reportedly died in Norway following their immunization with the Pfizer-BioNTech mRNA vaccine against Covid-19.<br />
<br />
On the other hand, several countries have halted the use of AstraZeneca as the shot may have caused some recipients to develop blood clots.<br />
<br />
Recently, the regional health authorities in Italy's Lombardy region have said that public confidence in the country's use of the AstraZeneca Covid-19 vaccine has been hindered by the jab's safety fears.<br />
<br />
This week, the Therapeutic Goods Administration (TGA), Australia's medical regulator, has ruled that a 48-year-old woman's death due to blood clotting was a side effect of the AstraZeneca coronavirus vaccine.<br />
<br />
Meanwhile, Hyderabad-based pharmaceutical major Dr. Reddy's Laboratories (DRL) has received permission from the Drugs Controller General of India (DCGI) to import the Sputnik V vaccine in India for restricted use in emergencies.<br />
<br />
After Covishield and Covaxin, Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, is now the third Covid-19 vaccine to get emergency use approval in India.<br />
<br />
This week, the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) reported that the Sputnik V Covid-19 vaccine showed a 97.6 per cent efficacy.</p>
<p>
<em>(IANS)</em></p>
<p>
<em><br />
</em></p>
<p>
 </p>
<p>
 </p>
<p>
 </p>